Pinoline May Be Utilized as a Probe for CYP 2 D 6 Activity

[1]  Masahiro Hiratsuka,et al.  Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A–B, 18, 27, 36, 39, 47–51, 53–55, and 57) , 2008, Drug Metabolism and Disposition.

[2]  A. Yu.  Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions , 2008, The AAPS Journal.

[3]  F. Gonzalez,et al.  Cytochrome P450 Expression and Regulation in CYP3A4/CYP2D6 Double Transgenic Humanized Mice , 2008, Drug Metabolism and Disposition.

[4]  S. Wrighton,et al.  Comparative Metabolic Capabilities and Inhibitory Profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17 , 2007, Drug Metabolism and Disposition.

[5]  G. Y. Tang,et al.  Pinoline and N-acetylserotonin reduce glutamate-induced lipid peroxidation in retinal homogenates , 2007, Neuroscience Letters.

[6]  U. Fuhr,et al.  Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping , 2007, European Journal of Clinical Pharmacology.

[7]  L. Fuentes-Broto,et al.  Protective effect of melatonin and pinoline on nitric oxide-induced lipid and protein peroxidation in rat brain homogenates , 2006, Neuroscience Letters.

[8]  F. Gonzalez,et al.  Cytochrome P450 and xenobiotic receptor humanized mice. , 2006, Annual review of pharmacology and toxicology.

[9]  T. Herraiz,et al.  Endogenous and Dietary Indoles: A Class of Antioxidants and Radical Scavengers in the ABTS Assay , 2004, Free radical research.

[10]  J. Idle,et al.  Polymorphic Cytochrome P450 2D6: Humanized Mouse Model and Endogenous Substrates , 2004, Drug metabolism reviews.

[11]  N. Morgan,et al.  Effects of the beta-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans. , 2003, European journal of pharmacology.

[12]  J. Idle,et al.  Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. , 2003, Pharmacogenetics.

[13]  Ulrich M. Zanger,et al.  Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[14]  A. Rettie,et al.  Expression, Purification, Biochemical Characterization, and Comparative Function of Human Cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 Allelic Isoforms , 2002, Journal of Pharmacology and Experimental Therapeutics.

[15]  J. Idle,et al.  The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse. , 2001, Molecular pharmacology.

[16]  M Schwab,et al.  Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. , 2001, Pharmacogenetics.

[17]  R. Reiter,et al.  Increased levels of oxidatively damaged DNA induced by chromium(III) and H2O2: protection by melatonin and related molecules , 2000, Journal of pineal research.

[18]  J. Harro,et al.  Behavioural effects of pinoline in the rat forced swimming, open field and elevated plus-maze tests. , 1996, Pharmacological research.

[19]  M. Airaksinen,et al.  Major pharmacological effects of 6-methoxytetrahydro-beta-carboline, a drug elevating the tissue 5-hydroxytryptamine level. , 1978, Arzneimittel-Forschung.

[20]  B. Ho,et al.  Metabolism of 6-methoxytetrahydro- -carboline in rats. , 1972, Xenobiotica; the fate of foreign compounds in biological systems.